Sean Pokorney, MD, director of the arrhythmia core lab, Duke Clinical Research Institute, assistant professor of Medicine, Duke University, discusses a late-breaking ACC 2022 study that shows mortality is higher in patients with implantable electrophysiology (EP) device infections where the leads are not explanted.

The study's authors examined data from the DANAMI-3 trial, focusing on such outcomes as all-cause mortality, recurrent MI and target vessel revascularization.

The downward trend in annual mammography adherence should serve as a call to action for new processes to engage breast cancer survivors, physicians urged.

Along with X-rays, the new outposts will also offer primary care, lab work, EKGs, behavioral health, dental, optical, and hearing services, all for a flat fee, the retailer reported. 

Mass General cardiologist and Harvard professor Ami Bhatt, MD, predicts upcoming paradigm shifts in cardiology over the next decade. 

Accredited U.S. programs have reported sizable monthly screening deficits for lung, breast, and colorectal cancer, researchers reported recently. 

Cardiothoracic surgeon Igor Mokryk, MD, spent last week taking his family to the Polish border. This week, he treated his first gunshot wound patient at the Heart Institute in Kyiv.

The study's authors emphasized the importance of careful patient selection.